EXEL·Exelixis Inc.
EXEL|Analyst Targets
EXEL|Insider Trading
EXEL|Fundamentals
EXEL|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.90 | - | - |
| Q3'25 | $0.67 | $0.78 | +16.2% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $662M | - | - |
| Q3'25 | - | $598M | - |
EXEL|Monthly Returns
Market Data
EXEL Stock Snapshot
- Market cap
- 15.05B
- P/E ratio
- 17.5
- Day range
- $58.59 – $60.00
- News sentiment
- 72/100 · Bullish
- Analyst target
- $54.87 (-7.8%)
- Consensus
- Hold · 28 analysts
Exelixis Inc. screens well technically, with price sitting near its 52-week high. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.
Behaviour On Record
What EXEL's own history says about today's numbers
- Realized volatility (21d)
- 26.4% 9th pct
- Below its peak
- 0.0%
- vs 200-day average
- +21.2%
- Up days (1y)
- 53%
Exelixis Inc. is currently running 26.4% annualised volatility over the last 21 sessions. Measured against EXEL's own 13 years of daily returns rather than a market-wide average, that is the 9th percentile — unusually subdued by its own history, against a typical reading of 43.1%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
EXEL is at its running peak. Across 12 full years on file its median worst-drawdown-in-a-year was -34.6%, with the deepest at -84.4% in 2014 — so highs have historically been given back before they were extended.
Price sits +21.2% from its 200-day moving average. Against every other day in its history, that gap ranks at the 75th percentile — a somewhat wider gap than its own norm. Over the past year EXEL closed higher on 53% of sessions, and it is currently 3 sessions into a rising streak.
On October specifically: over 13 years of records, EXEL finished the month higher 5 of 13 times, with a median return of -6.8% and an average of -3.3%. Its strongest month historically has been November at +7.3% on average, its weakest March at -4.1%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: EXEL has opened more than 2% away from the prior close in 386 of 3,266 sessions (11.8% of the time), with the largest gaps running +40.7% and -27.1%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,267 daily closes between 2013-10-14 and 2026-10-09, split-adjusted, recomputed daily. Percentiles are against EXEL's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of EXEL's sector?
Exelixis Inc. sits in the Health Care sector, currently ranked 4th of 12 GICS sectors by relative-strength rotation score (improving). Within its narrower Biotechnology industry group, EXEL ranks 13th of 15 tracked industries, lagging.
- Sector rank
- #4 of 12
- Sector state
- Improving
- Sector rotation score
- 73
- Industry rank
- #13 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on EXEL?
RBC Capital most recently reiterated its rating on Exelixis Inc. to Sector Perform on Oct 9, 2026 with a price target of $51 (from $45). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- RBC Capital — Sector Perform
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
ETF holders
ETFs holding EXEL
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | ▼ Sell | 29,075,377 | 11.49% | $1.58B | 2026-08-07 |
| Vanguard Group Inc | ▼ Sell | 25,490,449 | 10.08% | $1.12B | 2026-01-29 |
| Renaissance Technologies LLC | ▼ Sell | 13,427,993 | 5.31% | $730.62M | 2026-08-13 |
| AQR Capital Management LLC | ▼ Sell | 11,023,943 | 4.36% | $598.60M | 2026-08-14 |
| Geode Capital Management, LLC | ▼ Sell | 7,650,316 | 3.02% | $416.32M | 2026-08-12 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 5,551,747 | 2.19% | $302.07M | 2026-08-14 |
| Morgan Stanley | ▲ Buy | 4,519,684 | 1.79% | $245.92M | 2026-08-13 |
| Invesco Ltd. | ▲ Buy | 4,495,697 | 1.78% | $244.61M | 2026-08-14 |
| Two Sigma Investments, LP | ▲ Buy | 4,209,861 | 1.66% | $229.06M | 2026-08-14 |
| Goldman Sachs Group Inc | ▲ Buy | 2,690,489 | 1.06% | $146.39M | 2026-08-14 |
| Norges Bank | ▲ Buy | 2,688,866 | 1.06% | $146.30M | 2026-08-12 |
| Bank of America Corp | ▲ Buy | 2,149,397 | 0.85% | $116.95M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 2,126,094 | 0.84% | $115.68M | 2026-08-13 |
| JPMorgan Chase & Co | ▲ Buy | 1,298,907 | 0.51% | $71.08M | 2026-08-12 |
| Millennium Management LLC | ▲ Buy | 1,218,706 | 0.48% | $66.31M | 2026-08-14 |
| FMR LLC (Fidelity) | ▼ Sell | 1,147,913 | 0.45% | $62.46M | 2026-08-13 |
| Gotham Asset Management, LLC | ▼ Sell | 892,663 | 0.35% | $48.57M | 2026-08-14 |
| Marshall Wace, LLP | ▲ Buy | 831,506 | 0.33% | $45.24M | 2026-08-13 |
| Janus Henderson Group plc | ▲ Buy | 913,802 | 0.36% | $39.20M | 2026-05-18 |
| Wells Fargo & Company | ▲ Buy | 717,840 | 0.28% | $39.06M | 2026-08-14 |
| Squarepoint Ops LLC | ▲ Buy | 473,707 | 0.19% | $25.77M | 2026-08-14 |
| Man Group plc | ▼ Sell | 456,761 | 0.18% | $24.85M | 2026-08-14 |
| Bridgewater Associates, LP | ▼ Sell | 400,859 | 0.16% | $21.81M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 280,850 | 0.11% | $15.28M | 2026-08-03 |
| AllianceBernstein L.P. | ▲ Buy | 344,215 | 0.14% | $14.76M | 2026-08-14 |